ODI Pharma AB (publ)
Research ODI Pharma AB (publ) (ODI.ST) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- TickerODI.ST
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencySEK
- Financial periodQ2 2026
- RevenueSEK 3.20M
- Net incomeSEK 153.04K
- Free cash flowSEK 364.19K
- Gross margin52.6%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 19.84M | -SEK 744.22K | -SEK 2.01M | 29.3% | -0.04 | SEK 4.76M | n/a | SEK 1.93M |
About ODI Pharma AB (publ)
ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products. ODI Pharma AB (publ) was founded in 2018 and is based in Stockholm, Sweden.
Related stock research
Other Healthcare stocks
BioGaia AB (publ) (BIOG-B)
Cinclus Pharma (CINPHA)
Cereno Scientific AB Series B (CRNO-B)
Dicot AB (DICOT)
Enzymatica publ AB (ENZY)
EQL Pharma (EQL.ST)
Enorama Pharma AB (ERMA)
Gabather AB (publ) (GABA)
Klaria Pharma Holding (KLAR.ST)
Moberg Pharma (MOB.ST)
Nanexa AB (NANEXA)
Newbury Pharmaceuticals AB (NEWBRY)
Frequently asked questions
What does ODI Pharma AB (publ) do?
ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products. ODI Pharma AB (publ) was founded in 2018 and is based in Stockholm, Sweden.